WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Abbott Laboratories earnings were $13.5B for the trailing 12 months ending Mar 31, 2025, with 139% growth year over year. The latest ABT earnings report on Mar 31, 2025 announced Q1 2025 earnings of $1.3B, down 85.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABT reported annual earnings of $13.4B, with 134.2% growth. The next ABT earnings date is Jul 16, 2025.

ABT past earnings growth

How has ABT's earnings growth performed historically?

Company
139.01%
Industry
48.93%
Market
34%
ABT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ABT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ABT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ABT earnings history

Current Revenue
$42.3B
Current Earnings
$13.5B
Current Profit Margin
31.9%
ABT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ABT Return on Equity

Current Company
30.6%
Current Industry
7.2%
Current Market
31.5%
ABT's Return on Equity (30.6%)... subscribe to Premium to read more.
High Return on Equity Performance

ABT undefined

Current Company
17.4%
Current Industry
9.2%
ABT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABT announces earnings.

ABT undefined

Current Company
11.55%
Current Industry
9.3%
ABT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABT vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABT$11.07B$13.50B+30.75%$7.72
BSX$4.09B$2.03B-14.83%$1.38
SYK$3.76B$2.86B+5.31%$7.50
MDT$8.63B$4.26B-3.52%$3.31
EW$4.56B$4.18B+31.62%$7.03
View Top Medical Device Stocks

ABT earnings dates

Next earnings date
Jul 16, 2025

Abbott Laboratories Earnings Reports & History FAQ

What were Abbott Laboratories's earnings last quarter?

On ABT's earnings call on Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q1 2025 earnings per share (EPS) of $0.76, up 8.57% year over year. Total ABT earnings for the quarter were $1.33 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.70.

If you're new to stock investing, here's how to buy Abbott Laboratories stock.

When does Abbott Laboratories report earnings?

The next ABT earnings call is Invalid Date. Add ABT to your watchlist to be reminded of Abbott Laboratories's next earnings date.

What was ABT's earnings growth in the past year?

As of Abbott Laboratories's earnings date in Invalid Date, Abbott Laboratories's earnings has grown 139.01% year over year. This is 90.08 percentage points higher than the US Medical Devices industry earnings growth rate of 48.93%. ABT earnings in the past year totalled $13.50 billion.

Is Abbott Laboratories profitable or losing money?

As of the last Abbott Laboratories earnings report, Abbott Laboratories is currently profitable. Abbott Laboratories's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $13.50 billion, a 139.82% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.